Thus, we treated HCC cells with the proteasome inhibitor MG132 and we found that it efficiently blocked the downregulation of ATF4 induced by the siRNA‐mediated depletion of YAP/TAZ (Appendix Fig S7A). Here, WWTR1 is linked to hepatocellular carcinoma.